Cargando…

Comparison of risk factors between preterm and term infants hospitalized for severe respiratory syncytial virus in the Russian Federation

BACKGROUND: Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infection in infants. Preterm birth, in addition to several demographic and environmental factors, increases the risk for development of severe RSV infection. The purpose of this study was to describe differe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gooch, Katherine L, Notario, Gerard F, Schulz, Gregory, Gudkov, Konstantin M, Buesch, Katharina, Khong, Hoa, Campbell, Andrew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2011
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3140809/ https://www.ncbi.nlm.nih.gov/pubmed/21792335 http://dx.doi.org/10.2147/IJWH.S16608

Ejemplares similares

Epidemiology of respiratory syncytial virus in children ≤2 years of age hospitalized with lower respiratory tract infections in the Russian Federation: a prospective, multicenter study
por: Tatochenko, Vladimir, et al.
Publicado: (2010)

A prospective, open-label, non-comparative study of palivizumab prophylaxis in children at high risk of serious respiratory syncytial virus disease in the Russian Federation
por: Turti, Tatyana V, et al.
Publicado: (2012)

A cost-effectiveness analysis of respiratory syncytial virus (RSV) prophylaxis in infants in the United Kingdom
por: Bentley, Anthony, et al.
Publicado: (2013)

Epidemiology of Respiratory Syncytial Virus Infection in Preterm Infants
por: Resch, Bernhard, et al.
Publicado: (2011)

Burden of Severe Respiratory Syncytial Virus Disease Among 33–35 Weeks’ Gestational Age Infants Born During Multiple Respiratory Syncytial Virus Seasons
por: Anderson, Evan J., et al.
Publicado: (2017)

Respiratory Syncytial Virus Hospitalizations in Healthy Preterm Infants: Systematic Review
por: Mauskopf, Josephine, et al.
Publicado: (2016)

Suptavumab for the Prevention of Medically Attended Respiratory Syncytial Virus Infection in Preterm Infants
por: Simões, Eric A F, et al.
Publicado: (2020)

Risk scoring tool to predict respiratory syncytial virus hospitalisation in premature infants
por: Blanken, Maarten O., et al.
Publicado: (2018)

Respiratory syncytial virus hospitalization outcomes and costs of full-term and preterm infants
por: McLaurin, K K, et al.
Publicado: (2016)

Assessing Variation in the Cost of Palivizumab for Respiratory Syncytial Virus Prevention in Preterm Infants
por: Shahabi, Ahva, et al.
Publicado: (2017)

Impact of Respiratory Syncytial Virus–Confirmed Hospitalizations on Caregivers of US Preterm Infants
por: Pokrzywinski, Robin M., et al.
Publicado: (2019)

Bioprinting in the Russian Federation: Can Russians Compete?
por: Timashev, Peter, et al.
Publicado: (2020)

Effectiveness of palivizumab immunoprophylaxis in preterm infants against respiratory syncytial virus disease in Qatar
por: Abushahin, Ahmad, et al.
Publicado: (2018)

Long-Term Burden and Respiratory Effects of Respiratory Syncytial Virus Hospitalization in Preterm Infants—The SPRING Study
por: Carbonell-Estrany, Xavier, et al.
Publicado: (2015)

Chronic respiratory diseases and risk factors in 12 regions of the Russian Federation
por: Chuchalin, Alexander G, et al.
Publicado: (2014)

Respiratory syncytial virus acute respiratory infection‐associated hospitalizations in preterm Mexican infants: A cohort study
por: Benítez‐Guerra, Daniela, et al.
Publicado: (2020)

Prolonged Seasonality of Respiratory Syncytial Virus Infection among Preterm Infants in a Subtropical Climate
por: Hsu, Chyong-Hsin, et al.
Publicado: (2014)

Chronologic Age at Hospitalization for Respiratory Syncytial Virus Among Preterm and Term Infants in the United States
por: Parikh, Rohan C., et al.
Publicado: (2017)

Cost-effectiveness of rule-based immunoprophylaxis against respiratory syncytial virus infections in preterm infants
por: Blanken, Maarten O., et al.
Publicado: (2017)

IFI27 may predict and evaluate the severity of respiratory syncytial virus infection in preterm infants
por: Gao, Junyan, et al.
Publicado: (2021)

Review of the home care programmes for respiratory syncytial virus (RSV) prophylaxis in Ireland and The Netherlands
por: Whelan, Barbara, et al.
Publicado: (2016)

Seasonal peaks and risk factors of respiratory syncytial virus infections related hospitalization of preterm infants in Taiwan
por: Chi, Hsin, et al.
Publicado: (2018)

Respiratory Syncytial Virus Disease: Immunoprophylaxis Policy Review and Public Health Concerns in Preterm and Young Infants
por: Staebler, Suzanne, et al.
Publicado: (2020)

Cooperation between the Russian Federation and CERN
Publicado: (1993)

The phylodynamics of the rabies virus in the Russian Federation
por: Deviatkin, Andrei A., et al.
Publicado: (2017)

Russian Federation: mental healthcare and reform
por: Krasnov, Valery, et al.
Publicado: (2010)

On the Support of the Oilfield Service in the Russian Federation
por: Zhdaneev, O. V., et al.
Publicado: (2021)

Respiratory Syncytial Virus Disease in Preterm Infants in the US Born at 32–35 Weeks Gestation Not Receiving Immunoprophylaxis
por: Ambrose, Christopher S., et al.
Publicado: (2014)

1413. Trends in Risk of Respiratory Syncytial Virus Hospitalizations in Preterm Infants Over a 10-Year Period
por: Kong, Amanda M, et al.
Publicado: (2020)

The disease burden of respiratory syncytial virus in Infants
por: Munro, Alasdair P.S., et al.
Publicado: (2023)

RESPIRATORY SYNCYTIAL AND OTHER VIRUSES ASSOCIATED WITH RESPIRATORY DISEASE IN INFANTS
por: Jacobs, J.W., et al.
Publicado: (1971)

Retrospective Study of the Clinical Epidemiological Characteristics of Pertussis in Infants Prior to Their First Vaccination in the Russian Federation
por: Lobzin, Yury V., et al.
Publicado: (2015)

The expanding epidemic of HIV-1 in the Russian Federation
por: Beyrer, Chris, et al.
Publicado: (2017)

COVID-19 as Occupation Disease in Russian Federation
por: Bukhtiyarov, Igor
Publicado: (2022)

Ozone Content over the Russian Federation in 2020
por: Ivanova, N. S., et al.
Publicado: (2021)

Drug control and human rights in the Russian Federation
por: Hellman, Matilda
Publicado: (2022)

Regional Convergence or Polarization: The Case of the Russian Federation
por: Taymaz, E.
Publicado: (2023)

Transgender population in the Russian Federation: diversity and trends
por: Solovieva, Nadezhda V., et al.
Publicado: (2023)

Current Trends of HIV Infection in the Russian Federation
por: Ogarkova, Daria, et al.
Publicado: (2023)

IRIS: Infection with RespIratory Syncytial Virus in infants—a prospective observational cohort study
por: Wetzke, Martin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_h51knn3tm5v3c7lov2uii3cf33